Burning Rock Biotech Limited (BNR)

Deferred Revenue

¥109.21M

Quarterly · Period ending: · CNY

BNR logo

BNR Deferred Revenue

Latest reported¥109.21M CNY
BNR Quarterly Deferred Revenue · CNY (¥0.00 → ¥109.21M)
High-resolution chart · PNG

BNR deferred revenue history

Quarterly · CNY. Dates are reporting period ends; fiscal years can differ from calendar years.

Burning Rock Biotech Limited Deferred Revenue — Quarterly (CNY)
Period endingDeferred Revenue (CNY)
109,208,608
115,079,000
107,887,657
0
103,392,000
117,792,000
118,487,000
111,315,000
120,549,000
128,713,000
131,734,000
145,484,000
148,510,000
155,514,000
149,436,000
168,663,000
164,145,000
160,120,000
143,843,000
123,757,000
102,559,000
92,133,000
75,522,000
83,185,000
73,274,000
55,242,000
53,643,000
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.